Early DAS Response After DMARD-start Increases Probability of Achieving Sustained DMARD-free Remission in Rheumatoid Arthritis Marloes Verstappen, MD – Leiden University Medical Center
3:10 PM – 3:20 PM ET
Impact of Targeting Remission or Low Disease Activity on 10-year Severity in Rheumatoid Arthritis : Data from ESPOIR Cohort Julia Dupont, -None- – University Hospital of Toulouse
3:20 PM – 3:30 PM ET
Subclinical Synovitis in Arthralgia: How Often Does It Result in Clinical Arthritis? A Longitudinal Study to Reflect on Starting Points for DMARD Treatment Cleo Rogier, MD – Erasmus MC
3:30 PM – 3:40 PM ET
Differential Influence of CDAI Components Based on Disease State in Rheumatoid Arthritis Patients: Real World Results from a Rheumatoid Arthritis Cohort Emmanouil Rampakakis, PhD – JSS Medical Research
3:40 PM – 3:50 PM ET
Can a Clinical Disease Activity Index Based on Patient-Reported Joint Counts (PT-CDAI) Be Used to Inform Target-Based Care in Telemedicine? An Analysis of 2 Early RA Cohort Studies Vivian P. Bykerk, MD, FRCPC – Hospital for Special Surgery
